Abstract
An Elizabethkingia meningoseptica infection was detected at the end stage of a patient with T-cell non-Hodgkin’s lymphoma. The complete genome of this isolated strain, FMS-007, was generated in one contig with a total size of 3,938,967 bp. A preliminary screening indicated that the genome contains drug resistance genes to aminoglycosides and β-lactams. A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (CRISPR/Cas) system with 16 direct repeats and 15 spacers was identified.
GENOME ANNOUNCEMENT
Elizabethkingia meningoseptica, also known as Flavobacterium meningosepticum, is a nonfermenting, nonmotile, oxidase-positive, Gram-negative bacillus. Studies indicate that clinical E. meningoseptica infection may cause meningitis, sepsis, respiratory infection, and other clinical conditions, and the case fatality rate is around 25% (1–3). Although reports regarding E. meningoseptica-associated infections are rare, an epidemiological study indicated that the infection is emerging in Taiwan (2), and it is listed in an official survey as one of the top five clinically isolated nonfermenting Gram-negative bacilli in China (4). In this paper, we report the complete genome of E. meningoseptica strain FMS-007, a strain isolated from a 15-year-old intensive care unit (ICU) patient with T-cell non-Hodgkin’s lymphoma.
The genomic DNA of FMS-007 was extracted and sequenced with a HiSeq 2000 (Illumina, San Diego, CA) using a whole-genome shotgun strategy. A complete genome of 3,938,967 bp (35.6% G+C content) in one circularized chromosome was generated using SOAPdenovo V1.05 software. No plasmids or phages were detected. Compared to the other reported draft genome sequences of E. meningoseptica strains (5–7), the FMS-007 genome is complete and in one contig. With this unique feature, the genome could be used as an ideal template for genomic studies of E. meningoseptica and related species.
The gene annotation of the whole genome of FMS-007 was conducted using KEGG, TrEMBL, GO, and COG databases. The results indicated that FMS-007 contains 3,625 putative genes, 5 ribosome RNA operons, and 52 tRNAs. A preliminary screening for drug resistance genes was conducted. An extended-spectrum β-lactamase subtype CME-2, a metalloenzyme subtype BlaB−11, GOB-1, and AmpC were identified. Aminoglycoside resistance gene analysis revealed that FMS-007 contained several candidate genes for aminoglycoside resistance, including one 16S rRNA methylase, two aminoglycoside phosphotransferases, and one aminoglycoside nucleotidyltransferase. In addition, a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (CRISPR/Cas) system containing 3 Cas enzymes and a CRISPR cassette with 16 direct repeats and 15 spacers was identified. Current literature indicates that CRISPR enzymes and the CRISPR RNAs may act together as an adaptive immune system to eliminate invaded exogenous DNAs, including phages and/or plasmids (8). The potential role of the detected CRISPR/Cas system in infection and other functions deserves further attention.
Nucleotide sequence accession number.
This whole-genome shotgun project has been deposited in GenBank under the accession no. CP006576.
ACKNOWLEDGMENTS
We gratefully acknowledge Yumei Wen and Doug Chen for suggestions and discussions.
This work was supported by Fudan University funding (EZF101507), the National Science Technology Major Project of China, and the Natural Science Foundation of Ningbo (2012ZX10003008-010, 2013ZX10004802-002, 2013A610274).
Footnotes
Citation Sun G, Wang L, Bao C, Li T, Ma L, Chen L. 2015. Complete genome sequence of Elizabethkingia meningoseptica, isolated from a T-cell non-Hodgkin’s lymphoma patient. Genome Announc 3(3):e00673-15. doi:10.1128/genomeA.00673-15.
REFERENCES
- 1.Pereira GH, Garcia Dde O, Abboud CS, Barbosa VL, Silva PS. 2013. Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen. Braz J Infect Dis 17:606–609. doi: 10.1016/j.bjid.2013.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hsu MS, Liao CH, Huang YT, Liu CY, Yang CJ, Kao KL, Hsueh PR. 2011. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur J Clin Microbiol Infect Dis 30:1271–1278. doi: 10.1007/s10096-011-1223-0. [DOI] [PubMed] [Google Scholar]
- 3.Sun GQ, Yu X, Bao C, Wang L, Li M, Gan JH, Qu D, Ma JB, Chen L. 2015. Identification and characterization of a novel prokaryotic peptide: N-glycosidase from Elizabethkingia meningoseptica. J Biol Chem 290:7452–7462. doi: 10.1074/jbc.M114.605493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hu YJ. 2008. 2006–2007 Mohnarin report: antibiotics resistance of nonfermenting Gram-negative bacilli. Chin J Antibiot 33:597–601. (In Chinese.) [Google Scholar]
- 5.Matyi SA, Hoyt PR, Hosoyama A, Yamazoe A, Fujita N, Gustafson JE. 2013. Draft genome sequences of Elizabethkingia meningoseptica. Genome Announc 1(4):e00444-13. doi: 10.1128/genomeA.00444-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Quick J, Constantinidou C, Pallen MJ, Oppenheim B, Loman NJ. 2014. Draft genome sequence of Elizabethkingia meningoseptica isolated from a traumatic wound. Genome Announc 2(3):e00355-14. doi: 10.1128/genomeA.00355-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pradeep BE, Mahalingam N, Manivannan B, Padmanabhan K, Nilawe P, Gurung G, Chhabra A, Nagaraja V. 2014. Draft genome sequence of Elizabethkingia meningoseptica, isolated from a postoperative endophthalmitis patient. Genome Announc 2(6):e01335-14. doi: 10.1128/genomeA.01335-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marraffini LA, Sontheimer EJ. 2010. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11:181–190. doi: 10.1038/nrg2749. [DOI] [PMC free article] [PubMed] [Google Scholar]